These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7192114)

  • 1. [Pharmacology of N-(2-imidazolin-2-yl)-N-(4-indanyl)amino (indanazoline), a new vasoconstrictive imidazoline compound].
    Kretzschmar R; Lehmann HD; Gries J; Kuhne J; Neumann W
    Arzneimittelforschung; 1980; 30(10):1746-60. PubMed ID: 7192114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On the decongesting effect of the novel imidazole derivative N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline) (author's transl)].
    Masing H; Bengel HJ
    Arzneimittelforschung; 1980; 30(10):1785-7. PubMed ID: 6159902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis of N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline) (author's transl)].
    May HJ
    Arzneimittelforschung; 1980; 30(10):1733-7. PubMed ID: 7192113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic study on N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline), a new rhinologic drug].
    Neumann B; Brode E; Traut M
    Arzneimittelforschung; 1980; 30(10):1771-85. PubMed ID: 6159901
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal experiments on the cardiovascular effects of lofexidine.
    Graf E; Doppelfeld IS; Prop G
    Arzneimittelforschung; 1982; 32(8a):941-55. PubMed ID: 6890368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxicity studies on N-(2-imidazolinew-2-yl)-N-(4-indanyl)amine monohydrochloride (indanazoline), a ne rhinologic drug].
    Worstmann W; Leuschner F; Neumann W; Kretzschmar R
    Arzneimittelforschung; 1980; 30(10):1760-71. PubMed ID: 6159900
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular actions of moxonidine: a possible role for imidazoline receptors.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The general pharmacology of a novel antitussive compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the galenical development of a nose spray from N-(2-imidazolin-2-yl)-N-(4-indanyl)amine monohydrochloride (indanazoline) (author's transl)].
    Dechow HJ; Lämmerhirt K; Pich CH; Schikarski M
    Arzneimittelforschung; 1980; 30(10):1738-46. PubMed ID: 6159899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines .
    Rondu F; Le Bihan G; Wang X; Lamouri A; Touboul E; Dive G; Bellahsene T; Pfeiffer B; Renard P; Guardiola-Lemaitre B; Manechez D; Penicaud L; Ktorza A; Godfroid JJ
    J Med Chem; 1997 Nov; 40(23):3793-803. PubMed ID: 9371245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
    Teschendorf HJ; Kretzschmar R; Kreiskott H; Weifenbach H
    Arzneimittelforschung; 1981; 31(9a):1580-8. PubMed ID: 7197973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denzimol, a new anticonvulsant drug. II. General pharmacological activities.
    Graziani G; Cazzulani P; Luca C; Nava G; Testa R
    Arzneimittelforschung; 1983; 33(8):1161-8. PubMed ID: 6685494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacology of loracarbef in animals.
    Shetler T; Bendele A; Buening M; Clemens J; Colbert W; Deldar A; Helton D; McGrath J; Shannon H; Turk J
    Arzneimittelforschung; 1993 Jan; 43(1):60-70. PubMed ID: 8447851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.